Under the FDAs Interim Policy on Compounding Using Bulk Drug Substances, the agency has stated that it does not intend to take enforcement action against pharmacies that compound with bulk drug substances listed in Category 1, provided the pharmacy otherwise complies with the conditions of section 503A
Though the current research suggests that TB4 and TB-500 may be able to support various aspects of your bodys general health and wellness, theyre most often promoted as ways to: Repair or regenerate tissue (e.g., heal injuries, boost muscle recovery) Lower inflammation Promote blood vessel formation Protect certain organs (e.g., heart, liver, and eyes) These potential benefits also have some of the most promising research behind them, though its important to keep in mind that the majority of the data on TB4 (and TB-500) to date is from preclinical studies done on cells or animal subjects
Did the FDA Legalize BPC-157, TB-500, KPV and MOTS-c
Timing your injection matters
GHK-Cu's ability to suppress TGF-1 secretion suggests a mechanism distinct from but complementary to finasteride (which blocks androgen conversion) and minoxidil (which stimulates growth directly)
At 4 mg retatrutide / 0.8 mg cagrilintide per week (the upper end of community-reported maintenance for both), the smaller vial provides roughly 3 weeks at maintenance and the larger vial roughly 5 weeks